Diagnos Laboratorium Utama Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp109 (market cap 1.46T, 537.8K 24h volume). The key difference: Putra Mandiri Jembar Tbk. is far larger — about 4.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 537.8K). Which is the better fit depends on your goals.
| DGNS | PMJS | |
|---|---|---|
Market Cap | 310.75B | 1.46T |
Volume | 963.6K | 537.8K |
Lot | 9.64K | 5.38K |
Turnover | 217.67M | 57.74M |
Average Price | 225.89 | 107.37 |
Value | 217.67M | 57.74M |
Indicative Equilibrium Price | 226 | 109 |
Indicative Equilibrium Volume | 1K | 759 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →